Koch Kevin (CIK 0001185829)

Latest company ownership

Shares held
338,784
Last filed at
Mar 25, 2021
Confidence Score
48.2
2025Q4
Confidence Score History
2023Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 12, 2025 Aug 14, 2025 Edgewise Therapeutics, Inc. CEO Sell 42.5 -7,972 -2.11% ✗ $106.8K
May 1, 2025 May 7, 2025 Edgewise Therapeutics, Inc. CEO Sell 42.5 -4,276 -1.10% ✗ $70.4K
Mar 7, 2025 Mar 11, 2025 Edgewise Therapeutics, Inc. CEO Sell 58.8 -100 -0.03% ✓ $3K
Feb 5, 2025 Feb 7, 2025 Edgewise Therapeutics, Inc. CEO Sell 38.8 -9,536 -2.53% ✓ $287.3K
May 1, 2024 May 3, 2024 Edgewise Therapeutics, Inc. CEO Sell 45.0 -3,152 -0.88% ✗ $59.6K
May 1, 2023 May 3, 2023 Edgewise Therapeutics, Inc. CEO Sell 48.8 -3,203 -0.92% ✗ $28.5K